| __timestamp | Protagonist Therapeutics, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7459000 | 47795223 |
| Thursday, January 1, 2015 | 11831000 | 50426000 |
| Friday, January 1, 2016 | 25705000 | 70853000 |
| Sunday, January 1, 2017 | 46181000 | 78168000 |
| Monday, January 1, 2018 | 59497000 | 123757000 |
| Tuesday, January 1, 2019 | 65003000 | 140963000 |
| Wednesday, January 1, 2020 | 74506000 | 131773000 |
| Friday, January 1, 2021 | 126006000 | 210328000 |
| Saturday, January 1, 2022 | 126215000 | 235780000 |
| Sunday, January 1, 2023 | 120161000 | 244990000 |
Infusing magic into the data realm
In the ever-evolving world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Protagonist Therapeutics, Inc. and Travere Therapeutics, Inc. have demonstrated significant investment in R&D, reflecting their dedication to advancing medical science.
From 2014 to 2023, Travere Therapeutics consistently outpaced Protagonist in R&D expenditure, with a peak in 2023 where Travere's spending was nearly double that of Protagonist. Notably, Travere's R&D expenses grew by approximately 413% from 2014 to 2023, while Protagonist saw an impressive increase of around 1,511% over the same period. This substantial growth underscores the dynamic nature of the biotech sector and the relentless pursuit of groundbreaking therapies.
As these companies continue to invest heavily in R&D, the potential for innovative treatments and therapies remains promising, offering hope for patients worldwide.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Protagonist Therapeutics, Inc.
R&D Insights: How GSK plc and Protagonist Therapeutics, Inc. Allocate Funds
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Protagonist Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Travere Therapeutics, Inc.
Analyzing R&D Budgets: Verona Pharma plc vs Travere Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development Expenses Breakdown: Protagonist Therapeutics, Inc. vs Wave Life Sciences Ltd.
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Protagonist Therapeutics, Inc. vs MiMedx Group, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Travere Therapeutics, Inc. vs Xencor, Inc.